ENVESTNET ASSET MANAGEMENT INC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 152 filers reported holding REVANCE THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 2.06 and the average weighting 0.2%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$219,639
-66.0%
19,149
-24.9%
0.00%
Q2 2023$645,456
+3.4%
25,502
+31.6%
0.00%
Q1 2023$624,004
+17.3%
19,373
-32.8%
0.00%
Q4 2022$531,999
+37.8%
28,819
+101.4%
0.00%
Q3 2022$386,000
+162.6%
14,310
+34.1%
0.00%
Q2 2022$147,000
-40.0%
10,668
-14.9%
0.00%
Q1 2022$245,000
-26.0%
12,543
-38.2%
0.00%
Q4 2021$331,000
-66.5%
20,294
-42.8%
0.00%
-100.0%
Q3 2021$989,000
-4.4%
35,491
+1.6%
0.00%0.0%
Q2 2021$1,035,000
+206.2%
34,933
+189.2%
0.00%
Q1 2021$338,000
+24.3%
12,080
+26.1%
0.00%
Q4 2020$272,0000.0%9,583
-11.4%
0.00%
Q3 2020$272,000
+6.7%
10,813
+3.4%
0.00%
Q2 2020$255,000
+59.4%
10,456
-3.4%
0.00%
Q1 2020$160,000
-19.6%
10,828
-11.7%
0.00%
Q4 2019$199,000
+19800.0%
12,262
+45314.8%
0.00%
Q2 2017$1,0000.0%270.0%0.00%
Q1 2017$1,0000.0%270.0%0.00%
Q4 2016$1,000270.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders